Boston University Libraries OpenBU
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • Theses & Dissertations
    • Boston University Theses & Dissertations
    • View Item
    •   OpenBU
    • Theses & Dissertations
    • Boston University Theses & Dissertations
    • View Item

    Glycation of collagen interferes with discoidin domain receptor 2 (DDR2) mediated collagen induction of lysyl oxidase in osteoblasts

    Thumbnail
    Date Issued
    2013
    Author(s)
    Khosravi, Roozbeh
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/11104
    Abstract
    Diabetes doubles the risk of bone fracture. Poor quality of bone in diabetes is largely linked to diminished bone formation and bone organic phase abnormalities. Studies indicated that in diabetes, glycation of type I collagen, the most abundant protein in bone extracellular matrix, prompts abnormal arrangement of collagen molecules leading to weak bones. In addition, diabetic bone fragility is attributed to reduced levels of lysyl oxidase enzyme-dependent collagen cross-links. However, the mechanism underlying the presence of lower levels of enzymatic collagen cross-links in diabetic bone has not been directly investigated. Thus, we investigated the regulation of lysyl oxidase in bone under diabetic conditions. Our in-vitro model examined collagen and glycated-collagen regulation of lysyl oxidase in primary rodent osteoblasts. Our findings indicate that collagen up-regulates lysyl oxidase in osteoblasts, while glycated-collagen fails to regulate lysyl oxidase. To determine the mechanism of collagen upregulation of lysyl oxidase, we studied two classes of collagen receptors: Discoidin Domain-Receptor 2 (DDR2) and integrins. Inhibitor and knockdown studies indicated that collagen up-regulates lysyl oxidase through DDR2. Furthermore, glycated-collagen-DDR2 binding and activation analyses showed that collagen glycation disrupted collagen-DDR2 binding and activation, pointing to a mechanism for the diminished levels of lysyl oxidase and consequent low lysyl oxidase-derived cross-links in diabetic bone. Our in-vivo studies focused on lysyl oxidase regulation in mouse calvarial bone healing tissues under diabetic conditions. These experiments revealed that diabetes up-regulates lysyl oxidase mRNA and enzyme activity in partially healed bone (day 7). We next performed histological analyses on day 7 healing bone. Data suggest that hematomas, which form in the initial stage of bone healing, do not resolve in diabetic mice. Unresolved hematomas are rich in growth factors, which could explain elevated levels of lysyl oxidase in diabetic healing bone. Taken together, this study provides a novel mechanism by which collagen glycation disrupts the regulation of lysyl oxidase in diabetic bone fragility. Additionally, we found that the excess formation of non-mineralized fibrotic matrix might be one of the mechanisms behind impaired intramembranous bone healing in diabetes.
    Description
    Thesis (Ph.D.)--Boston University
    Collections
    • Boston University Theses & Dissertations [7858]


    Boston University
    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Boston University
    Contact Us | Send Feedback | Help